Serum Takes Its Investment In Biocon Bio To $300 Million, Kiran M Shaw On This & More | Cnbc-Tv18

Serum takes its investment in Biocon Bio to $300 Million, Kiran M Shaw On This & More | CNBC-TV18

'Serum Keen To Have Stake In Biocon Biologics,' Kiran Mazumdar-Shaw On ET Now

Kiran Mazumdar-Shaw, Executive Chairperson, Biocon & Biocon Biologics speaking on Q2 FY25 Results

From ₹10,000 to a Global Legacy: The Kiran Mazumdar-Shaw Story 👑💊

B2L Women's Network | Global

Facts about billionaire and founder of Biocon "Kiran Mazumdar-Shaw".

Kiran Mazumdar-Shaw on Biocon's journey from Startup to Billion Dollar Pharma Company | Podcast

From Code To Culture

From ₹10K to ₹29K Crore: Kiran Mazumdar-Shaw's Inspiring Journey. #biocon

Biocon Biologics: on a mission to make universal access to insulins a reality

Founder Stories: Kiran Mazumdar, Founder of Biocon

Exclusive | Biocon Biologics Q4: Serum Will Double Investment To $300 Mn

Kiran Mazumdar - Shaw, Executive Chairperson, Biocon Speaking on Q3FY22 Earnings

Company Is Exploring Equity Investment Opportunities To Reduce Debt: Biocon's Kiran Mazumdar-Shaw

Kiran Mazumdar-Shaw: Business Leader Facts #business #facts #india

Biocon To Buy Viatris' Assets | Kiran Shaw On The Deal Rationale

Kiran Mazumdar Shaw life journey|biocon #shorts #entrepreneur #youtubeshorts #trending #viral

Our acquisition of Viatris business has been 'spooking the Indian investor,' biotechnology firm says

CNBC International News

LIVE | Biocon Is Not For Sale, Ignore Rumours: Founder Kiran Mazumdar-Shaw | India Ideas Summit

Biocon Eyes Equity Investments for Debt Reduction Says Kiran Mazumdar-Shaw | Exclusive | CNBC TV18

Kiran Mazumdar Shaw Of Biocon Talks About Biocon's Milestone | Exclusive

Biocon Biologics to acquire Viatris Inc's biosimilars business

The Hindu businessline